| MR编号 | CZ/H/0801/003 |
|---|
| 药品名称 | Octreotide Teva |
|---|
| 活性成分 | - Octreotide acetate 30.0 mg
|
|---|
| 剂型 | Powder and solvent for suspension for injection |
|---|
| 上市许可持有人 | Teva B.V.
Swensweg 5, Haarlem
2031GA
Netherlands |
|---|
| 参考成员国 - 产品名称 | Czechia (CZ) OCTREOTIDE TEVA |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
Octreoteva Long Acting 30 mg poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte - Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
Octreoanne 30 mg stungulyfsstofn og leysir, dreifa - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Octreoanne - Finland (FI)
- Poland (PL)
Okteva - Estonia (EE)
OCTREOTIDE TEVA - Hungary (HU)
OKTREOTID TEVA 30 mg por és oldószer retard szuszpenziós injekcióhoz - Bulgaria (BG)
Octreotide LAI Teva - Romania (RO)
- Slovenia (SI)
- Croatia (HR)
Oktreotid Teva 30 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem
|
|---|
| 许可日期 | 2019/04/16 |
|---|
| 最近更新日期 | 2025/07/18 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|